Blepharophimosis-intellectual disability syndrome, ohdo type is a rare genetic condition that affects facial development, eyelids, and learning. People with this condition often have narrow eye openings, distinctive facial features, and developmental delays or intellectual disability. Signs are usually noticed in infancy or early childhood and tend to be lifelong. Treatment focuses on supportive care such as early therapies, special education, and sometimes eyelid or cleft-related surgery, and not everyone will have the same experience. The outlook varies, but many people with Blepharophimosis-intellectual disability syndrome, ohdo type live into adulthood with coordinated care and family support.
Overview
Blepharophimosis-intellectual disability syndrome, ohdo typeSymptoms
Blepharophimosis-intellectual disability syndrome, Ohdo type, is usually recognized at birth, with very narrow eyelid openings, droopy lids, and distinctive facial features. Other signs include low muscle tone, infant feeding difficulties, delayed milestones and speech, intellectual disability, and sometimes hearing loss.
Outlook and prognosis
Most children with Blepharophimosis–intellectual disability syndrome, Ohdo type, grow and learn at their own pace with lifelong differences in learning and facial muscle control. Early therapies, vision care, and tailored education can improve everyday skills and communication. Regular follow‑up helps address changing needs over time.
Causes and risk factors
Blepharophimosis-intellectual disability syndrome, Ohdo type usually results from a new single-gene variant. Some families have autosomal dominant or X-linked inheritance. Family history, rare parental mosaicism, and advanced paternal age affect recurrence risk; environment may modify severity, not cause.
Genetic influences
Genetics play a central role in Blepharophimosis-intellectual disability syndrome, ohdo type. Most cases arise from rare, single-gene variants that disrupt early development. Inheritance can be autosomal dominant or recessive, and some cases result from new (de novo) variants.
Diagnosis
Doctors suspect it from characteristic eyelid shape, facial features, and developmental delays. Diagnosis of Blepharophimosis-intellectual disability syndrome, ohdo type is confirmed with genetic tests; eye exams and imaging may support findings. Early referral to clinical genetics and ophthalmology helps.
Treatment and drugs
Treatment for Blepharophimosis‑intellectual disability syndrome, Ohdo type focuses on each person’s needs. Care often blends eyelid surgery to widen vision, speech and occupational therapy, educational supports, and help with feeding, sleep, or behavior. Regular check‑ins coordinate eye care, development, and genetics.
Symptoms
Families often first notice differences in the eyes and early development that affect daily routines, like feeding, focusing, or making facial expressions. Many parents first notice early features of Blepharophimosis-intellectual disability syndrome, ohdo type in the way the eyelids look and how milestones unfold. Features vary from person to person and can change over time. This genetic condition is present from birth and tends to involve the eyelids, facial movement, muscle tone, and learning.
The openings between the eyelids are smaller than usual, giving the eyes a narrowed look. Clinicians call this blepharophimosis, which means the eyelid opening is reduced. It is a hallmark of Blepharophimosis-intellectual disability syndrome, ohdo type.
Upper eyelids may sit low and partly cover the pupil. Clinicians call this ptosis, which means the lids do not lift fully.
Facial expressions can look reduced or mask-like. This can make emotions harder to read and may affect chewing or speech clarity.
Muscles feel looser and provide less resistance than typical in Blepharophimosis-intellectual disability syndrome, ohdo type. In medical terms, this is hypotonia; in everyday life, it shows up as a floppy feel in infancy and quick fatigue during play.
How people usually first notice Blepharophimosis-intellectual disability syndrome, ohdo type?
Many families first notice something unusual at birth or in the first months: very narrow eye openings with droopy eyelids, a broad nasal bridge, and sometimes a small jaw or widely spaced teeth. As babies grow, doctors may note feeding difficulties, low muscle tone, and delayed milestones like sitting or babbling, which lead to developmental evaluations. These early facial features together with developmental delays are the most common first signs of Blepharophimosis–intellectual disability syndrome, Ohdo type, and often prompt genetic testing to confirm how the condition is first noticed.
Types of Blepharophimosis-intellectual disability syndrome, ohdo type
Blepharophimosis–intellectual disability syndrome, Ohdo type is a rare genetic condition with a few recognized clinical variants. These variants share a core pattern—eyelid narrowing, distinctive facial features, and developmental differences—but can differ in severity, associated health issues, and timing of milestones. Clinicians often describe them in these categories:
Classic Ohdo type
Facial features and eyelid narrowing are prominent from birth. Most have moderate to severe developmental delays and limited or absent speech. Feeding difficulties and low muscle tone are common in infancy.
SBBYS variant
Features are similar but often include a broader nose, distinctive mouth shape, and more pronounced eyelid changes. Developmental delay can be severe with minimal speech. Some have joint stiffness or differences in bone development.
VCF-related variant
This variant overlaps with velo‑cardio‑facial features, including palate differences and possible heart defects. Developmental delay ranges from mild to moderate. Early speech therapy can make a noticeable difference in communication.
Milder-spectrum cases
Core facial features are present but less marked, and motor milestones may be closer to typical. Intellectual disability may be mild, with better receptive language than expressive speech. Not everyone will experience every type.
Atypical/overlap presentations
Some people show a blend of features that do not fit neatly into one subtype. Doctors use genetic testing and the overall pattern of signs to guide the label. Keeping track of which types of Blepharophimosis–intellectual disability syndrome, Ohdo type features are present can help tailor therapies.
What genetics can tell you about symptoms
Some with KAT6B gene changes develop tight, narrow eyelid openings, broad nasal bridge, and a small jaw, along with low muscle tone and feeding challenges in infancy. These variants can also disrupt brain development, leading to delayed speech, learning difficulties, and sometimes heart or thyroid issues.
Causes and risk factors
Blepharophimosis-intellectual disability syndrome, Ohdo type results from a change in a single gene that is present from conception, either new or inherited. The genetic causes of Blepharophimosis-intellectual disability syndrome, Ohdo type can involve KAT6B or, in some families, MED12. If inherited, KAT6B changes follow an autosomal dominant pattern, and MED12 changes are X-linked with males typically more affected. Genetic testing can sometimes clarify your personal risk. There are no known lifestyle or environmental causes, but family history is the main risk factor and healthy habits support overall health.
Environmental and biological risk factors
Blepharophimosis-intellectual disability syndrome, Ohdo type usually begins before birth, so the main influences happen at or before conception. While families may look for early symptoms of Blepharophimosis-intellectual disability syndrome, Ohdo type, this section focuses on factors that may make it more likely to occur in the first place. Doctors often group risks into internal (biological) and external (environmental). At present, only a few biological patterns are linked to higher chance, and consistent environmental triggers have not been shown.
Conception with an older father is linked to a higher rate of new biological changes in sperm cells. This can slightly raise the chance of rare conditions that begin before birth, including Blepharophimosis-intellectual disability syndrome, Ohdo type. For any one pregnancy, the increase remains small.
No specific exposure in the home, workplace, or community has been shown to cause this syndrome. Plenty of people with similar exposures live without developing the condition.
Genetic risk factors
Most cases trace back to a single gene change present from birth. Some risk factors are inherited through our genes. In Blepharophimosis-intellectual disability syndrome, Ohdo type, the KAT6B gene is most often involved, and the change usually occurs for the first time in the child. When a parent carries the same change, it follows an autosomal dominant pattern with a 50% chance of passing it to each child.
KAT6B gene variants: Changes in the KAT6B gene are the main genetic cause of Blepharophimosis-intellectual disability syndrome, Ohdo type. They disrupt how this gene guides early development of the face, eyes, and brain. In many families, the exact variant influences which features are most prominent.
Autosomal dominant pattern: One altered copy of KAT6B is enough to cause the condition. If a parent has the same change, each child has a 50% (1 in 2) chance to inherit it.
De novo variants: Most people have a new change that arose in the egg or sperm rather than being inherited. This usually means parents test negative, and future recurrence risk is low but not zero.
Parental mosaicism: Sometimes a parent carries the gene change in only some cells, with few or no outward signs. Mosaicism can slightly increase the chance of the condition recurring in another pregnancy.
Copy-number changes: Larger missing or extra pieces of DNA that include KAT6B can also cause similar features. These changes alter gene dosage and can be found by tests that look for missing or extra DNA.
Variable expression: People with Blepharophimosis-intellectual disability syndrome, Ohdo type can be affected to different degrees even within the same family. The same genetic change can lead to a range of learning, facial, and movement features.
Genetic testing: Genetic testing for Blepharophimosis-intellectual disability syndrome, Ohdo type can confirm a KAT6B change and clarify inheritance. A result helps inform family planning and testing of siblings or other relatives.
Lifestyle risk factors
Lifestyle choices do not cause this condition, but daily habits can meaningfully shape symptoms, participation, and complications over time. This overview explains how lifestyle affects Blepharophimosis-intellectual disability syndrome, ohdo type, focusing on practical areas families can influence. Tailored routines around eating, moving, sleeping, and communication can make care easier and outcomes better. Work with clinicians to individualize these strategies for your needs.
Careful food textures can lower choking risk in Ohdo syndrome. Smaller, slower meals may improve intake and reduce reflux.
Energy-dense, nutrient-rich foods support growth when feeding is effortful. Monitoring weight helps prevent both undernutrition and excess gain from limited activity.
Adequate fluids and fiber can ease constipation linked to low muscle tone. Regular bowel routines may reduce discomfort and behavioral distress.
Low-impact activity and physiotherapy can strengthen postural control and mobility in Ohdo syndrome. Better strength and balance may decrease falls and improve participation.
Risk prevention
You can’t prevent this genetic condition, but you can lower the chances of avoidable problems and support healthy development. Prevention works best when combined with regular check-ups. Many families find that noticing early symptoms of Blepharophimosis-intellectual disability syndrome, Ohdo type—such as eyelid narrowing that affects vision or feeding and speech delays—helps them act sooner with targeted care. The steps below focus on reducing complications, improving vision and communication, and planning supports across childhood.
Meet with a genetics professional to understand recurrence risk and testing options. This can include preconception carrier discussions, prenatal screening, or diagnostic testing if desired.
See a pediatric eye specialist to protect vision and plan timing of eyelid procedures if needed. Early treatment can reduce amblyopia (“lazy eye”) and support visual development.
Start early intervention with speech, occupational, and physical therapy. Consistent therapy builds communication, mobility, and daily living skills over time.
Ask for a feeding and swallow evaluation if there is coughing, choking, or poor weight gain. Targeted strategies can lower aspiration risk and make mealtimes safer.
Transmission
Blepharophimosis-intellectual disability syndrome, Ohdo type is a genetic condition present from birth; it is not contagious and cannot be caught or spread through everyday contact, coughing, or bodily fluids. In many people, it happens because of a new change in a gene in the egg or sperm, so there may be no family history. In some families, Blepharophimosis-intellectual disability syndrome, Ohdo type can be passed from a parent to a child; how Blepharophimosis-intellectual disability syndrome, Ohdo type is inherited depends on the specific gene change. A genetics team can explain the genetic transmission of Blepharophimosis-intellectual disability syndrome, Ohdo type in your family and discuss chances for future pregnancies.
When to test your genes
Consider genetic testing if there’s a family history of blepharophimosis with developmental delays, or if a child shows early signs such as small eye openings, facial differences, and learning or speech delays. Testing helps confirm the diagnosis, guide therapies and school supports, and inform surgical planning. It also clarifies recurrence risk for future pregnancies.
Diagnosis
You might notice small changes in daily routines, like a child’s eyelids seeming narrow or droopy and milestones taking longer than expected. Over time, these patterns often lead families to seek answers from their care team about Blepharophimosis-intellectual disability syndrome, ohdo type. Early and accurate diagnosis can help you plan ahead with confidence. Doctors typically consider how someone looks, learns, and grows, then confirm the cause with targeted genetic tests.
A careful physical exam looks for the hallmark narrow eyelid openings, droopy lids, and other facial features that tend to travel together. Providers also note low muscle tone, feeding challenges, and unique dental or jaw shape. Recognizing this pattern guides which tests to order next.
An eye specialist measures eyelid opening, checks for ptosis, and assesses eye movements and alignment. These findings help document the specific eyelid changes seen in this condition. Results support the overall clinical picture before genetic confirmation.
Standardized tools track speech, motor, and learning milestones. Documenting strengths and delays helps define the neurodevelopmental profile. This information also directs early therapies while testing proceeds.
A genetics lab can analyze the KAT6B gene, often through a multigene panel or exome sequencing. A confirmed variant provides the genetic diagnosis of Blepharophimosis-intellectual disability syndrome, ohdo type and clarifies recurrence risk for families. Results can also inform screening for associated health needs.
Stages of Blepharophimosis-intellectual disability syndrome, ohdo type
Blepharophimosis-intellectual disability syndrome, Ohdo type does not have defined progression stages. It’s a genetic condition present from birth; features like narrow eyelid openings, differences in muscle tone, and learning or speech challenges may change with age, but they don’t follow a predictable, stepwise pattern. Doctors usually start with a conversation about early symptoms of Blepharophimosis-intellectual disability syndrome, Ohdo type and a physical exam, then may add vision checks, developmental evaluations, and other assessments based on needs. Genetic testing may be offered to confirm the cause and guide care plans, therapies, and eye management over time.
Outlook and prognosis
Daily life with Blepharophimosis-intellectual disability syndrome, ohdo type can involve ongoing therapies for learning, communication, feeding, and facial differences that may affect vision or speech. Many people ask, “What does this mean for my future?”, and the answer depends on the mix of features each person has and how early support begins. Early care can make a real difference, especially for early symptoms of Blepharophimosis-intellectual disability syndrome, ohdo type like feeding challenges, slow developmental milestones, or vision issues that benefit from prompt treatment.
Doctors call this the prognosis—a medical word for likely outcomes. Most children with Blepharophimosis-intellectual disability syndrome, ohdo type grow into adulthood, and the condition itself is not usually life‑shortening. The biggest long‑term considerations are developmental and behavioral needs, plus medical issues such as heart differences, thyroid problems, or seizures if they are present; these can be managed with regular follow‑up. With ongoing care, many people maintain steady gains in communication, self‑care, and mobility, though the level of independence varies widely.
Looking at the long‑term picture can be helpful. Some people experience moderate to severe intellectual disability and will need lifelong support, while others notice more mild learning needs and can participate in supported work or community programs. The future may look uncertain now, but coordinated care—developmental pediatrics, speech and occupational therapy, ophthalmology, and genetics—sets up the best path forward. Talk with your doctor about what your personal outlook might look like, including monitoring for treatable complications that can affect health and quality of life over time.
Long-term effects
Long-term effects center on development, communication, and the distinctive eyelid and facial features that define the condition. Many people live into adulthood with stable health, though day-to-day independence often depends on cognitive and communication abilities. Long-term effects vary widely, and ongoing support can be tailored to each person’s needs. Over time, daily routines may revolve around vision care, communication supports, and monitoring for associated health differences.
Intellectual disability is typically moderate to severe. Learning tends to progress slowly and plateaus may occur. Daily living skills often require ongoing support into adulthood.
Speech is often limited or absent. Understanding language may be stronger than speaking. Many rely on alternative ways to communicate.
Narrow eyelid openings and droopy lids can limit visual range. Light sensitivity and reduced visual attention are common over the years. Early features of Blepharophimosis-intellectual disability syndrome, ohdo type often continue to affect vision in adulthood.
Low muscle tone and coordination challenges can persist. Walking and fine hand movements may be delayed and remain clumsy. Fatigue with long distances is common.
How is it to live with Blepharophimosis-intellectual disability syndrome, ohdo type?
Living with Blepharophimosis–intellectual disability syndrome, Ohdo type often means moving at a different pace in daily routines, with extra time and support for communication, learning, and self‑care. Many benefit from consistent therapies—speech, occupational, and physical therapy—to build skills, while caregivers structure the day with visual cues, simple steps, and predictable schedules to reduce stress. Socially, friends and family may notice unique facial features and communication differences, so gentle education and inclusive activities help others connect, while respite services and care coordination give families breathing room. With early interventions, patient advocacy, and a steady team of clinicians and therapists, many find a rhythm that supports comfort, safety, and meaningful participation at home, school, and in the community.
Treatment and drugs
Treatment for Blepharophimosis–intellectual disability syndrome, Ohdo type focuses on easing day‑to‑day challenges and supporting development over time rather than curing the underlying genetic change. Supportive care can make a real difference in how you feel day to day. Care plans often include early therapies such as speech, occupational, and physical therapy; vision care; hearing checks; and educational supports, with behavioral and developmental services added as needed. Some people with Blepharophimosis–intellectual disability syndrome, Ohdo type may benefit from eyelid surgery to widen the eye opening, treatments for dental or feeding issues, and medicines for specific features like attention, mood, sleep, seizures, or constipation. Your doctor can help weigh the pros and cons of each option, and it’s common for the plan to be updated as needs change.
Non-drug treatment
Daily life with Blepharophimosis-intellectual disability syndrome, ohdo type often centers on building communication, learning, and day-to-day independence while addressing vision and developmental needs. Early symptoms of Blepharophimosis-intellectual disability syndrome, ohdo type can include small eye openings, droopy lids, and delayed speech, so care tends to start early and be team-based. Beyond prescriptions, supportive therapies can help children gain skills over time. Plans are tailored, since abilities and needs vary from one child to another.
Coordinated services in infancy and preschool help build communication, motor, and self-care skills. Therapists set simple, measurable goals and coach families to practice at home.
Exercises target low muscle tone, balance, and coordination to support sitting, standing, and walking. Play-based sessions can reduce falls and improve endurance.
Hand skills and daily activities like dressing, feeding, and play are broken into small, achievable steps. Adaptive tools—like special grips or utensils—can make tasks easier.
Speech-language therapists work on sounds, understanding words, and safe swallowing. Augmentative and alternative communication (AAC), such as picture boards or speech-generating devices, can give a reliable voice while speech develops.
Your genes may have an impact on how drugs work for you
Genes can change how bodies process medications for blepharophimosis–intellectual disability syndrome, Ohdo type, affecting dose needs and side‑effect risk for drugs like anti‑seizure medicines, behavioral treatments, and anesthesia. Pharmacogenetic testing and careful dosing help tailor safer, more effective care.
Pharmacological treatments
There isn’t one medicine that treats the underlying gene change in Blepharophimosis-intellectual disability syndrome, Ohdo type, so drug therapy focuses on easing day-to-day symptoms. Depending on a person’s needs, medications can help with seizures, low thyroid, reflux, constipation, drooling, sleep, and attention. Not everyone responds to the same medication in the same way. Doctors tailor medications for Blepharophimosis-intellectual disability syndrome, Ohdo type to the individual and adjust them over time.
Levetiracetam or valproate are commonly used if seizures occur. Doses are increased gradually to balance seizure control with side effects.
Levothyroxine treats hypothyroidism when present. Regular blood tests guide dose changes to support energy, growth, and development.
Omeprazole or lansoprazole can reduce stomach acid and ease heartburn or feeding discomfort. A time-limited trial helps check benefit and side effects.
Polyethylene glycol (PEG 3350) softens stools and can make bowel movements more regular. Doses are adjusted to achieve one comfortable bowel movement daily.
Genetic influences
Most cases are linked to a change in a single gene called KAT6B, which helps guide early development of the eyes, face, and brain. It’s natural to ask whether family history plays a role. In many children, this change happens for the first time (a “de novo” variant) and isn’t inherited from either parent. When a parent does carry the same KAT6B change, it can be passed on, and each pregnancy has a 50% chance of inheriting it. Even within the same family, features of Blepharophimosis-intellectual disability syndrome, Ohdo type can vary in type and severity. Genetic testing can confirm a KAT6B change and help answer common questions like “Is Blepharophimosis-intellectual disability syndrome, Ohdo type inherited?”, and a genetic counselor can discuss your family’s recurrence risks and options for future pregnancies.
Is Blepharophimosis-intellectual disability syndrome, ohdo type genetic?
Genetics play a central role in Blepharophimosis-intellectual disability syndrome, ohdo type. Most cases arise from rare, single-gene variants that disrupt early development. Inheritance can be autosomal dominant or recessive, and some cases result from new (de novo) variants.
Pharmacogenetics—how genetics influence drug effects
In Blepharophimosis-intellectual disability syndrome, ohdo type, the underlying gene change confirms the diagnosis but usually doesn’t determine which medicines will work or how they’re dosed. Genes can influence how quickly you process certain medicines, which can matter for seizure drugs, pain relievers after surgery, and some attention or mood treatments. For example, codeine and tramadol rely on a common liver enzyme; very slow processors may get little pain relief, while very fast processors may have stronger effects or side effects. Some anti-seizure medicines and atomoxetine have established genetic dosing guidance, and people of certain Asian ancestries are often screened for an HLA type before starting carbamazepine to reduce the risk of a serious skin reaction. Pharmacogenetic testing is not specific to Blepharophimosis-intellectual disability syndrome, ohdo type; decisions about testing come from the particular medicine being considered and your ancestry and health history. Work with your care team to review any current or planned medicines—especially around procedures or seizures—and whether genetic information could help tailor dosing safely.
Interactions with other conditions
Day to day, many living with this condition also manage vision, hearing, thyroid, or heart problems that can affect energy, learning, and growth. Doctors call it a “comorbidity” when two conditions occur together, and in Blepharophimosis-intellectual disability syndrome, ohdo type, low muscle tone, feeding challenges, and congenital heart differences often travel with the core features. Untreated hypothyroidism can slow development and make fatigue and constipation worse, while hearing loss or frequent ear infections can compound speech and learning delays. Significant eyelid narrowing and droopy lids may limit vision, and when combined with eye misalignment (strabismus) or the need for glasses, this can increase fall risk and make classroom tasks harder. Some children also have sleep‑disordered breathing due to facial structure or weak airway muscles, so colds, asthma, or sedating medicines may have a stronger effect on breathing than expected. Because early symptoms of Blepharophimosis-intellectual disability syndrome, ohdo type can resemble other developmental conditions, coordinated care across pediatrics, cardiology, endocrinology, ophthalmology, audiology, and rehabilitation helps ensure treatments work together rather than against each other.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described families in which children were born with very narrow eye openings, unusual facial features, and developmental delays that affected speech and learning. Caregivers often noticed that milestones came later—sitting, first words, toileting—and doctors observed distinctive facial traits at checkups. In school, many with Blepharophimosis-intellectual disability syndrome, Ohdo type needed extra help with communication and motor skills, and some had feeding difficulties in infancy that gradually improved with support.
First described in the medical literature as a pattern linking tight eyelids (blepharophimosis), facial differences, and intellectual disability, early reports came from a handful of families. At the time, the exact borders of the condition were unclear, and different teams used overlapping names. Over time, descriptions became more consistent as clinicians compared notes, recognized the combination of facial features with developmental and sometimes hormonal findings, and separated Ohdo type from other look‑alike syndromes.
In recent decades, knowledge has built on a long tradition of observation. Detailed photographs, standardized checklists, and shared case registries helped show what was common—narrow palpebral fissures, a mask-like facial expression in some, low muscle tone in infancy—and what varied, such as level of intellectual disability, speech, and behavior. These historical steps also highlighted associated features occasionally seen by specialists, like dental differences or joint laxity, while reinforcing that vision, hearing, and heart findings could be present but were not universal.
Advances in genetics changed the storyline from “what we see” to “why it happens.” As researchers studied families with Blepharophimosis-intellectual disability syndrome, Ohdo type, they identified gene changes that act a bit like a dimmer switch turned too low during early development, affecting how facial structures, muscles, and the brain mature. This helped explain why the facial traits and developmental profile tend to travel together, and why the condition can appear for the first time in a child with no prior family history or run through multiple generations.
Understanding the history also improved care. Earlier recognition meant earlier referrals for therapies, eye and eyelid evaluations, and support for feeding and speech. Awareness that early symptoms of Blepharophimosis-intellectual disability syndrome, Ohdo type may be subtle in infancy but clearer by toddler years guided follow-up plans. Today, the name reflects both the key facial findings and the developmental needs, anchoring a journey that began with careful observations at the bedside and now includes precise genetic testing, clearer counseling for families, and more tailored support across childhood and adulthood.